During OMERACT 8, delegates selected patient global assessment (PGA) of disease as a domain to be evaluated in randomized controlled trials in psoriatic arthritis (PsA). This study assessed the reliability of the PGA, measured by means of 0-100 mm visual analog scale (VAS), and the additional utility of separate VAS scales for joints (PJA) and skin (PSA).
Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study / Cauli, Alberto; Gladman, Dafna D; Mathieu, Alessandro; Olivieri, Ignazio; Porru, Giovanni; Tak, Paul P; Sardu, Claudia; Ujfalussy, Ilona; Scarpa, Raffaele; Marchesoni, Antonio; Taylor, William J; Spadaro, Antonio; Fernàndez Sueiro, Jose L; Salvarani, Carlo; Kalden, Joachim R; Lubrano, Ennio; Carneiro, Sueli; Desiati, Francesca; Flynn, John A; D'Angelo, Salvatore; Vacca, Alessandra; VAN Kuijk, Arno W. R; Catanoso, Maria Grazia; Gruenke, Mathias; Peluso, Rosario; Parsons, Wendy J; Ferrara, Nicola; Contu, Paolo; Helliwell, Philip S; Mease, Philip J.. - In: THE JOURNAL OF RHEUMATOLOGY. - ISSN 0315-162X. - 38:(2011), pp. 898-903. [10.3899/jrheum.100857]
Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study
SALVARANI, CARLO;
2011
Abstract
During OMERACT 8, delegates selected patient global assessment (PGA) of disease as a domain to be evaluated in randomized controlled trials in psoriatic arthritis (PsA). This study assessed the reliability of the PGA, measured by means of 0-100 mm visual analog scale (VAS), and the additional utility of separate VAS scales for joints (PJA) and skin (PSA).
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
